SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-043040
Filing Date
2023-02-21
Accepted
2023-02-21 08:58:16
Documents
20
Period of Report
2023-02-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d464394d8k.htm   iXBRL 8-K 34824
2 EX-1.1 d464394dex11.htm EX-1.1 192486
3 EX-4.1 d464394dex41.htm EX-4.1 63092
4 EX-5.1 d464394dex51.htm EX-5.1 12272
5 EX-99.1 d464394dex991.htm EX-99.1 8425
9 GRAPHIC g464394g0221015327321.jpg GRAPHIC 2534
10 GRAPHIC g464394g0221015730931.jpg GRAPHIC 2534
11 GRAPHIC g464394g0221044107280.jpg GRAPHIC 3513
12 GRAPHIC g464394g0221085401939.jpg GRAPHIC 5113
  Complete submission text file 0001193125-23-043040.txt   540434

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA vrca-20230221.xsd EX-101.SCH 2850
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE vrca-20230221_lab.xml EX-101.LAB 18737
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vrca-20230221_pre.xml EX-101.PRE 11707
14 EXTRACTED XBRL INSTANCE DOCUMENT d464394d8k_htm.xml XML 3443
Mailing Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380
Business Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380 484-453-3300
Verrica Pharmaceuticals Inc. (Filer) CIK: 0001660334 (see all company filings)

IRS No.: 463137900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38529 | Film No.: 23645461
SIC: 2834 Pharmaceutical Preparations